Article info

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

Authors

  • Amanthi Nadira Arumahandi de Silva Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany PubMed articlesGoogle scholar articles
  • Leonie Maria Frommert Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany PubMed articlesGoogle scholar articles
  • Fredrik N Albach Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany PubMed articlesGoogle scholar articles
  • Jens Klotsche Epidemiology Unit, German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany PubMed articlesGoogle scholar articles
  • Veronika Scholz Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany PubMed articlesGoogle scholar articles
  • Lara Maria Jeworowski Institute of Virology, Charité Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany PubMed articlesGoogle scholar articles
  • Tatjana Schwarz Institute of Virology, Charité Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany PubMed articlesGoogle scholar articles
  • Alexander ten Hagen Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany PubMed articlesGoogle scholar articles
  • Jan Zernicke Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany PubMed articlesGoogle scholar articles
  • Victor Max Corman Institute of Virology, Charité Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany Labor Berlin, Charité - Vivantes GmbH, Berlin, Germany PubMed articlesGoogle scholar articles
  • Christian Drosten Institute of Virology, Charité Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, and German Centre for Infection Research (DZIF), Associated Partner Site, Berlin, Germany PubMed articlesGoogle scholar articles
  • Gerd-Rüdiger Burmester Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany PubMed articlesGoogle scholar articles
  • Robert Biesen Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Robert Biesen, Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Berlin, Germany; robert.biesen{at}charite.de
View Full Text

Citation

Arumahandi de Silva AN, Frommert LM, Albach FN, et al
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

Publication history

  • Received November 17, 2021
  • Accepted February 24, 2022
  • First published March 14, 2022.
Online issue publication 
May 16, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.